Telomir Pharmaceuticals Ownership | Who Owns Telomir Pharmaceuticals?


OverviewFinancialsChart

Telomir Pharmaceuticals Ownership Summary


Telomir Pharmaceuticals is owned by 6.37% institutional investors, 44.98% insiders, and 48.64% retail investors. Vanguard group is the largest institutional shareholder, holding 3.66% of TELO shares.

TELO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTelomir Pharmaceuticals6.37%44.98%48.64%
SectorHealthcare Stocks 232.86%10.65%-143.51%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group1.14M3.66%$1.51M
Blackrock funding, inc. /de285.45K0.92%$379.65K
Geode capital management223.55K0.72%$297.46K
Vanguard fiduciary trust135.54K0.39%$176.20K
Raymond james financial75.34K0.25%$104.72K
State street58.60K0.20%$81.45K
Bank of new york mellon51.45K0.15%$66.89K
Suncoast equity management51.19K0.15%$66.55K
Northern trust41.84K0.14%$58.16K
Pensionmark financial group37.04K0.11%$48.15K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Suncoast equity management51.19K0.01%$66.55K
Praetorian wealth management20.00K0.01%$26.60K
Morton capital management llc/ca12.66K0.00%$16.46K
Pensionmark financial group37.04K0.00%$48.15K
Resources investment advisors, llc.23.00K0.00%$29.90K
Kestra private wealth services11.00K0.00%$14.30K
Vestmark advisory solutions13.10K0.00%$17.42K
Clearstead advisors12.53K0.00%$16.29K
Regions financial10.64K0.00%$13.83K
Tower research capital llc (trc)1.25K-$1.74K

Top Buyers

HolderShares% AssetsChange
Vanguard fiduciary trust135.54K-135.54K
Raymond james financial75.34K-73.55K
Vanguard group1.14M-35.71K
Geode capital management223.55K-27.52K
Vestmark advisory solutions13.10K0.00%13.10K

Top Sellers

HolderShares% AssetsChange
Marshall wace, llp---75.77K
Y-intercept (hong kong)---64.42K
Charles schwab investment management---46.41K
Hightower advisors---43.00K
Hrt financial lp---28.89K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust135.54K-135.54K$176.20K
Vestmark advisory solutions13.10K0.00%13.10K$17.42K
Vanguard global advisers6.55K-6.55K$8.52K
Allworth financial lp12.00-12.00$15.00

Sold Out

HolderChange
True wealth design-3.00
Srs capital advisors-9.00
Nisa investment advisors-96.00
Russell investments group-104.00
Sterling capital management-148.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202525-19.35%1,978,496-15.17%610.55%8-42.86%6-53.85%
Sep 30, 202518-53.85%1,901,652-26.54%68.38%6-75.00%9-35.71%
Jun 30, 202542-2,793,154-24.36%96.10%2519.05%1614.29%
Mar 31, 20254213.51%3,694,1737.09%129.12%21-32.26%14-
Dec 31, 20243815.15%3,565,51874.27%1225.25%3239.13%--100.00%

Insider Transactions Trends


DateBuySell
2026 Q2--
2025 Q3--
2025 Q2--
2024 Q4--
2024 Q3--

TELO Ownership FAQ


Who Owns Telomir Pharmaceuticals?

Telomir Pharmaceuticals shareholders are primarily institutional investors at 6.37%, followed by 44.98% insiders and 48.65% retail investors. The average institutional ownership in Telomir Pharmaceuticals's industry, Biotech Stocks , is 382.13%, which Telomir Pharmaceuticals falls below.

Who owns the most shares of Telomir Pharmaceuticals?

Telomir Pharmaceuticals’s largest shareholders are Vanguard group (1.14M shares, 3.66%), Blackrock funding, inc. /de (285.45K shares, 0.92%), and Geode capital management (223.55K shares, 0.72%). Together, they hold 5.30% of Telomir Pharmaceuticals’s total shares outstanding.

Does Blackrock own Telomir Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Telomir Pharmaceuticals.

Who is Telomir Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Suncoast equity management is Telomir Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 51.19K Telomir Pharmaceuticals shares, valued at 66.55K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools